Build-to-rent schemes are taking over 12 months to sell as buyers request more thorough safety checks, investors have said.
Continued rollout of FemBloc, the breakthrough non-surgical permanent contraceptive solution, expands the Company’s presence in key European Markets -- ...
Total revenue growth of 7.5% year-on-year (“YoY”) to USD 1,115 million. EBITDA growth of 19.7% YoY to USD 524 million ...
The demand for sound financial advice has never been greater, yet the number of high quality advisors hasn’t kept pace.
In this episode, Cameron Joyce, Head of Research Insights at Preqin, explores how private markets could reshape portfolios ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback